| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC5234
|
|
|
|
|
| Submitter :
|
| Ms. donna legamaro
|
| Date & Time:
|
| 12/29/2006 08:12:59
|
|
|
|
|
| Organization :
|
| registered nurses of missouri
|
|
|
|
|
| Category :
|
| Health Professional
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| I am deeply concerned about your policy of using aborted fetal cell lines to manufacture vaccines. There are other ethical sources for vaccines that do not involve using stem cells from aborted babies. I urge you to reconsider your position.
|
|
|
|
|
|
|
|
|
|
|
|
|
|